Copyright: ©Author(s) 2026.
World J Gastroenterol. Apr 28, 2026; 32(16): 117443
Published online Apr 28, 2026. doi: 10.3748/wjg.v32.i16.117443
Published online Apr 28, 2026. doi: 10.3748/wjg.v32.i16.117443
| Name | Source | Related mechanisms | Experimental models | Ref. |
| Nicotiflorin | San-Ye-Qing | Inhibiting the NF-κB pathway and activating the NLRP3 inflammasome to exert anti-inflammatory effects | LPS + BMDMs | Ruan et al[39] |
| Berberine | Coptis chinensis Franch. | Inhibiting the PI3K/AKT/mTOR pathway by targeting IRGM1 | 2.0% DSS induced UC in C57BL/6 J mice | Meng et al[40] |
| Epiberberine | Coptidis Rhizoma | Activating intestinal FXR, regulating BAs metabolism/FGF15, and relieving intestinal BAs accumulation/inflammation | 3% DSS induced UC in C57BL/6 J mice | Chen et al[41] |
| Anemoside B4 | P. chinensis | Enhancing intestinal epithelial barrier via regulating MLCK-pMLC2 signaling | 3% DSS induced UC in C57BL/6 J mice | Feng et al[42] |
| Paeoniflorin | Paeonia emodi, Paeonia obovata | Targeting CDC42 inhibits the CDC42/JNK signaling pathway | 4.0% DSS induced UC in SD rats | Hu et al[43] |
| Benzoylpaeo-niflorin | Baishao | Suppressing ferroptosis by regulating Nrf2/SLC7A11/GPX4 signaling pathway | 3.5% DSS induced UC in C57BL/6 J mice | Tang et al[44] |
| Formononetin | Astragalus membranaceus | Regulating gut microbiota and M1/M2 macrophage polarization balance | 2.5% DSS induced UC in C57BL/6 J mice | Xiao et al[45] |
| Anemoside B4 | P. chinensis | Regulating Lactobacillus abundance, promoting SCFA metabolism/butyrate production, and activating the AhR pathway to inhibit ROS/NLRP3 inflammasome activation | 3% DSS induced UC in C57BL/6 J mice | Wu et al[46] |
| Gastrodin | Gastrodia elata | Promoting gut microbiota-derived tryptophan metabolite production and inhibiting inflammation via the AhR/NLRP3 pathway | 2.5% DSS induced UC in C57BL/6 J mice | Zhang et al[47] |
| Plantamajoside | Plantago | Regulating gut microbiota, enhancing intestinal barrier, increasing cystathionine β-synthase expression, and inhibiting the NF-κB pathway | 2.5% DSS induced UC in C57BL/6 J mice | Jia et al[48] |
| Morin | Moraceae family | Inhibiting MAPK/NF-κB pathways, regulating gut microbiota | 2.5% DSS induced UC in C57BL/6 J mice | Qiu et al[49] |
| Caffeic acid | Coffee, Argan | Alleviating intestinal injury by inhibiting the Toll/Imd signaling pathways and suppressing mitochondria damage-mediated apoptosis | 4% DSS induced UC in drosophila | Xiu et al[50] |
| Curcumin, tryptophan | Turmeric | Restoring intestinal barrier function, reducing oxidative stress and inflammation, and regulating gut microbiota homeostasis | 2.5% DSS induced UC in BALB/c mice | Jiang et al[51] |
| Vanillic acid | Vanilla bean | Inhibiting arachidonic acid metabolic pathway and promoting macrophage polarization from M1 to M2 phenotype | 2.5% DSS induced UC in C57BL/6 J mice | Zhao et al[52] |
| Gastrodin | Gastrodia elata Blume | Enriching the Akkermansia mucinniphila population | 2% DSS induced UC in BALB/c mice | Zhang et al[53] |
| Vanillic acid | Angelica sinensis | Regulating oxidative stress, inflammatory responses, macrophage polarization, and the AMPK signaling pathway | 2.5% DSS induced UC in BALB/c mice | Ma et al[54] |
| Theabrownin | Fu Brick Tea | Enhancing antioxidant and anti-inflammatory capacities, regulating gut microbiota, and participating in the AhR pathway | 1.5% DSS induced UC in C57BL/6 J mice | Yang et al[55] |
| Butylchloro-genate | Chaenomeles speciosa | Inhibiting the activation of the NLRP3 inflammasome | 4% DSS induced UC in C57BL/6 J mice | Huang et al[56] |
| Quercetin | Vegetables and Fruits | Regulating the gut microbiota-isovanillic acid-intestinal barrier axis | 3% DSS induced UC in BALB/c mice | Lei et al[57] |
| Proanthocyanidins | Ephedra sinica Stapf | Regulating gut microbiota and restoring impaired serum tryptophan and glycerophospholipid metabolism | 4% DSS induced UC in KM mice | Lv et al[58] |
| TCP80-1 | Tupistra chinensis Baker | Enhancing the intestinal barrier and promoting the proliferation and differentiation of intestinal stem cells into intestinal epithelial cells | 4% DSS induced UC in drosophila | Wang et al[59] |
| Kaji-ichigoside F1 | Rosa roxburghii Trat | Regulating gut microbiota and metabolism, and inhibiting the PI3K/AKT pro-inflammatory signaling pathway | 3% DSS induced UC in C57BL/6 J mice | Liu et al[60] |
| Fraxin | Cortex Fraxini | Inhibiting ROS production, reducing pro-inflammatory cytokines, and regulating the TLR4/NF-κB and MAPK signaling pathways | 2.5% DSS induced UC in C57BL/6 J mice | Sun et al[61] |
| Isosinensetin | Pericarpium Citri Reticulatae | Inhibiting the PI3K/AKT signaling pathway, alleviating oxidative stress and inflammatory responses, and enhancing barrier function | 3% DSS induced UC in C57BL/6 J mice | Li et al[62] |
| Homogalacturonan | Passiflora edulis f. flavicarpa | Enhancing MUC-2 expression and promoting epithelial barrier restoration | 5% DSS induced UC in Swiss mice | Mazeti et al[63] |
| Bergenin | Ardisia japonica | Reducing Bacteroides vulgatus abundance to regulate branched-chain amino acid metabolism, thereby inhibiting TLR4 and modulating the phosphorylation of NF-κB and mTOR | 2.5% DSS induced UC in C57BL/6 J mice | Huang et al[64] |
| Theabrownin | Pu-erh tea | Increasing Akkermansia abundance and intestinal epithelial barrier function, regulating CD4+ T cell differentiation and Treg/Th17 balance, and inhibiting TLR2/4-mediated MyD88-dependent NF-κB, MAPK, and AKT signaling pathways | 5% DSS induced UC in Swiss mice | Zhao et al[65] |
| Gypenosides | Gynostemma pentaphyllum | Regulating the tricarboxylic acid cycle and glutamine metabolism, modulating stem cell bioactivity, and promoting the repair of damaged mucosa | 3% DSS induced UC in C57BL/6 J mice | Yang et al[66] |
| Glycyrrhizic acid, patchouli alcohol | Huoxiang Zhengqi | Modulating 11β-HSD1-mediated endogenous corticosterone metabolism to exert anti-inflammatory effects | 2% DSS induced UC in C57BL/6 J mice | Wang et al[67] |
| Neohesperidin | Brassicaceae family plants | Inhibiting the MAPK/NF-κB inflammatory signaling pathway, maintaining intestinal barrier integrity, and regulating gut microbiota | 2.5% DSS induced UC in C57BL/6 J mice | Ju et al[68] |
| Linderanine C | Lindera aggregate | Inhibiting the MAPK signaling pathway and macrophage M1 polarization | 2.5% DSS induced UC in C57BL/6 J mice | Lan et al[69] |
| Loganic acid | Swertia cincta | Inhibiting TLR4/NF-κB-mediated inflammation and activating the SIRT1/Nrf2 antioxidant response | 2.5% DSS induced UC in BALB/c mice | Prakash et al[70] |
| Pulchinenoside B4 | Bai-Tou-weng-Tang | Targeting the CD1d-mediated AKT-STAT1-PRDX1-NF-κB signaling pathway and inhibiting NLRP3 inflammasome activation | 3% DSS induced UC in C57BL/6 J mice | Li et al[71] |
| Rhoifolin | Citrus grandis | Activating CEMIP/SLC7A11-mediated cystine uptake and inhibiting epithelial ferroptosis | 2.5% DSS induced UC in C57BL/6 J mice | Liu et al[72] |
| Berberine | Coptis chinensis Franch. | Modulating the bile acid/S1PR2/RhoA/ROCK pathway to restore intestinal epithelial barrier function | 2.5% DSS induced UC in C57BL/6 J mice | Yu et al[73] |
| Gypenoside LXXV | Gynostemma pentaphyllum | Targeting the glucocorticoid receptor to inhibit NF-κB-COX2 signaling and promote M1-to-M2 macrophage polarization | 2.5% DSS induced UC in C57BL/6 J mice | Wu et al[74] |
| Mangiferin | Pueraria tuberosa | Restoring colon length and body weight, and reducing inflammatory responses | Inducing colitis via rectal administration of 2 mL of 4% acetic acid in BALB/c mice | Dharmapuri et al[75] |
| Didymin | Citrus grandis | Regulating gut microbiota and altering metabolites, thereby modulating the STAT3 and NF-κB pathways | 2% DSS induced UC in ICR mice | Chu et al[76] |
| JNUTS013 | Marine fungi | Inhibiting inflammation through inducing NLRP3 protein degradation | 3% DSS induced UC in C57BL/6 J mice | Wang et al[77] |
| Isolinderalactone | Lindera aggregata | Binding to LXRα and upregulating the expression of LXRα target genes such as ABCA1, thereby activating the LXRα pathway and inhibiting macrophage M1 polarization | 2.5% DSS induced UC in C57BL/6 J mice | Huang et al[78] |
| Linderane | Lindera aggregata | Suppressing IL-6/STAT3-mediated Th17 differentiation and apoptosis resistance | 2.5% DSS induced UC in C57BL/6 J mice | Lai et al[79] |
| (-)-Fenchone | Foeniculum vulgare Mill | Enhancing intestinal barrier function, exerting anti-inflammatory and antioxidant effects, and regulating immune function | Inducing colitis via rectal administration of trinitrobenzene sulfonic acid in Wistar rats | Araruna et al[80] |
| Ganoderic acid A | Ganoderma lucidum | Regulating gut microbiota-related tryptophan metabolism (especially 3-IAld), activating the aryl hydrocarbon receptor, and inducing IL-22 production | 2.5% DSS induced UC in C57BL/6 J mice | Kou et al[81] |
| Oxymatrine | Sophora flavescens | Regulating ferroptosis and alleviating intestinal inflammation | 4% DSS induced UC in ICR mice | Gao et al[82] |
| Diosmin | Citrus grandis | Inhibiting PANoptosis, regulating gut microbiota and metabolites | 3% DSS induced UC in C57BL/6 J mice | Tan et al[83] |
| Naringenin | Citrus grandis | Activating the Nrf2 signaling pathway to exert antioxidant effects | 3.5% DSS induced UC in BALB/c mice | Li et al[84] |
| Dihydromyricetin | Ampelopsis grossedentata | Inhibiting the formation of neutrophil extracellular traps and regulating the HIF-1α/VEGFA signaling pathway | 3.5% DSS induced UC in C57BL/6 J mice | Ma et al[85] |
| Homoplantaginin | Salvia plebeia R. Brown | Regulating the MMP9-RLN2 signaling axis | 2.5% DSS induced UC in C57BL/6 J mice | Tao et al[86] |
| Apigenin | Citrus grandis | Regulating mast cell degranulation via the PAMP-MRGPRX2 feedback loop | 5% DSS induced UC in C57BL/6 J mice | Huang et al[87] |
| Natural product/active component | Trial design | Sample size | Ref. |
| Anthocyanin-rich extract | Multicenter, randomized, placebo-controlled, double-blind study | 48 | Biedermann et al[134] |
| Hudi enteric-coated capsule, modified Wumei pill, and Qingchang Wenzhong decoction | Multicenter, randomized, double-blind study | 143 | Li et al[135] |
| Zataria multiflora | Multicenter, randomized, placebo-controlled, triple-blind trial | 92 | Morvaridi et al[136] |
| Curcumin, resveratrol | Prospective multicenter three-arm RCT | 48 | Erol Doğan et al[137] |
| Zuoqing San | Single-center, double-blind study | 126 | Li et al[138] |
| 1-kestose | Randomized, double-blind, placebo-controlled pilot trial | 40 | Ikegami et al[139] |
| Curcumin-QingDai | A retrospective multicenter adult cohort study | 88 | Yanai et al[140] |
| Icanbelimod | Single-center, double-blind study | 28 | Lickliter et al[141] |
| Pegmispotide | Double-blind study | 29 | Allegretti et al[142] |
- Citation: Yu X, Zhao CX, Wang C. Research progress in the treatment of ulcerative colitis with natural products. World J Gastroenterol 2026; 32(16): 117443
- URL: https://www.wjgnet.com/1007-9327/full/v32/i16/117443.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i16.117443
